Head-to-head · WeighScore
Potere Health MD vs Rixa Health
The verdict
Potere Health MD takes it — 72.5/100 to 60.5/100.
Potere Health MD grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. Potere Health MD is a Utah-based, physician-led weight loss clinic offering semaglutide and tirzepatide in both FDA-approved and compounded forms via telehealth and in-person visits.
We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.
Factor by factor
The same six graded dimensions, side by side. See the methodology.
The numbers
| Metric | Potere Health MD | Rixa Health |
|---|---|---|
| WeighScore | 72.5/100 | 60.5/100 |
| Grade | C | C |
| Scorecard rank | #77 | #320 |
| Semaglutide | $80/mo (starting dose, compounded) | Not disclosed |
| Tirzepatide | $135/mo (starting dose, compounded) | Not disclosed |
| Coverage | 1 state | All 50 states |
| Brand-name access | Compounded only | Compounded only |
| Oral / sublingual | Injection only | Yes |
Graded #77 · C
Strengths
- Low starting pricing (about $80-$135/month) with no subscription lock-in
- Physician-led by a named MD, not automated messaging
- Third-party COA and LegitScript-certified pharmacy
- Both telehealth and in-person Utah visits with fast scheduling
Where it loses points
- Available in Utah only — a St George clinic offering telehealth within the state, not a national service
- The per-vial price is fixed, so the monthly cost rises steeply with the dose: the provider's own table runs about $20/mo at 0.25 mg, $80/mo at 1.0 mg and about $199/mo at 2.5 mg
- Medication is bought per vial up front rather than on a subscription, so there is no monthly rate to compare directly against a subscription programme
- Compounded semaglutide and tirzepatide are not FDA-approved finished products
Graded #320 · C
Strengths
- Functional-medicine, root-cause clinical approach
- Compounded and oral semaglutide plus tirzepatide offered
- Board-certified DO and FNP providers with years of experience
- Medication bundled with visits into a single price
- No charge until after approval
Where it loses points
- No public monthly pricing; quoted only during consultation
- Relies on compounded GLP-1, which is not FDA-approved as a finished drug
- A handful of states still listed as coming soon
- Branded GLP-1 medications are not the primary offering
- Requires ongoing monthly follow-up commitment
Also worth a look
Neither is our top-graded pick — CoreAge Rx leads the scorecard
Across all 499 providers, CoreAge Rx grades highest at 91.8/100 (A−). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.
Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.